Stock listing
Ascletis Pharma, Inc.
Selected listing: 2VJ · SWB · EUR · DE
Ascletis Pharma, Inc. (Stuttgart:2VJ), Health Technology. Latest release Oct 2, 2026: Ascletis' ASC36 35FDC Demonstrated Potential for Once-Monthly…

- Ticker
- Stuttgart:2VJ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Stuttgart
- Currency
- EUR
Latest news from Ascletis Pharma, Inc.
Ascletis' ASC36_35FDC Demonstrated Potential for Once-Monthly to Once-Quarterly Dosing and Robust Weight-Loss in Preclinical Studies Presented at EASD 2026
October 2, 2026
VOLUNTARY ANNOUNCEMENT - ASCLETIS' ASC36_35FDC DEMONSTRATED POTENTIAL FOR ONCE-MONTHLY TO ONCE-QUARTERLY DOSING AND ROBUST WEIGHT-LOSS IN PRECLINICAL STUDIES PRESENTED AT EASD 2026
October 2, 2026
Interim Report 2026
September 29, 2026
Ascletis Announces Positive Results from 28-Day Proof-of-Concept Clinical Study in U.S. for ASC50, a First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor for the Treatment of Plaque Psoriasis
September 28, 2026
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSITIVE RESULTS FROM 28-DAY PROOF-OF-CONCEPT CLINICAL STUDY IN U.S. FOR ASC50, A FIRST-IN-CLASS AND BEST-IN-CLASS ORAL SMALL MOLECULE IL-17A INHIBITOR FOR THE TREATMENT OF PLAQUE PSORIASIS
September 28, 2026
Research Ascletis Pharma, Inc.
Ascletis Pharma, Inc. company profile
View the public company page for Ascletis Pharma, Inc. on 6ix.
Ascletis Pharma, Inc. news
Read company news and market updates connected to Ascletis Pharma, Inc..
Ascletis Pharma, Inc. investor events
Find investor webinars, events, and replay context for Ascletis Pharma, Inc..
Alternate listings
1672:HKEX
HK · HKD
Alternate listing for Ascletis Pharma, Inc.; the primary context on this page is 2VJ:SWB.
2VJ:TRADEGATE
DE · EUR
Alternate listing for Ascletis Pharma, Inc.; the primary context on this page is 2VJ:SWB.
ASCLF:OTC
US · USD
Alternate listing for Ascletis Pharma, Inc.; the primary context on this page is 2VJ:SWB.
A2JRKN:LSX
DE · EUR
Alternate listing for Ascletis Pharma, Inc.; the primary context on this page is 2VJ:SWB.
2VJ:GETTEX
DE · EUR
Alternate listing for Ascletis Pharma, Inc.; the primary context on this page is 2VJ:SWB.
A2JRKN:LS
DE · EUR
Alternate listing for Ascletis Pharma, Inc.; the primary context on this page is 2VJ:SWB.
2VJ:FWB
DE · EUR
Alternate listing for Ascletis Pharma, Inc.; the primary context on this page is 2VJ:SWB.
2VJ:DUS
DE · EUR
Alternate listing for Ascletis Pharma, Inc.; the primary context on this page is 2VJ:SWB.
2VJ:MUN
DE · EUR
Alternate listing for Ascletis Pharma, Inc.; the primary context on this page is 2VJ:SWB.